ArticleJournal of psychiatric research2008
Functional impairment in body dysmorphic disorder: a prospective, follow-up study.
Article in Journal of psychiatric research, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
14 citing papers in PubMed, 70 citations in OpenAlex.
- Predictors of pharmacotherapy outcomes for body dysmorphic disorder: a machine learning approach.Psychological medicine · 2023Trial
- Efficacy and Posttreatment Effects of Therapist-Delivered Cognitive Behavioral Therapy vs Supportive Psychotherapy for Adults With Body Dysmorphic Disorder: A Randomized Clinical Trial.JAMA psychiatry · 2019Trial
- Pharmacotherapy Relapse Prevention in Body Dysmorphic Disorder: A Double-Blind, Placebo-Controlled Trial.The American journal of psychiatry · 2016Trial
- Delusionality and response to open-label fluvoxamine in body dysmorphic disorder.The Journal of clinical psychiatry · 2001Trial
- Disseminating cognitive-behavioral therapy for body dysmorphic disorder: Evaluating the efficacy of online provider training.Internet interventions · 2026Article
- Preoperative Screening for Body Dysmorphic Disorder in Facial Plastic Surgery: Protocol Development and Validation.Aesthetic plastic surgery · 2026Article
- The effects of body dysmorphic disorder on women's quality of life and body image at difference stages of pregnancy.BMC pregnancy and childbirth · 2024Article
- Body Dysmorphic Disorder: Clinical Overview and Relationship to Obsessive-Compulsive Disorder.Focus (American Psychiatric Publishing) · 2021Article
- Predictors of Response to Cognitive-Behavioral Therapy for Body Dysmorphic Disorder.Behavior therapy · 2019Article
- Shame and Defectiveness Beliefs in Treatment Seeking Patients With Body Dysmorphic Disorder.The Journal of nervous and mental disease · 2018Article
- Article
- Body dysmorphic disorder: some key issues for DSM-V.Depression and anxiety · 2010Review
- Body dysmorphic disorder.Dialogues in clinical neuroscience · 2010Review
- High-dose glycine treatment of refractory obsessive-compulsive disorder and body dysmorphic disorder in a 5-year period.Neural plasticity · 2009Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors at 3 institutions in 1 country.
Funding
Abstract
Cross-sectional/retrospective studies indicate that individuals with body dysmorphic disorder (BDD) have markedly impaired psychosocial functioning. However, no study has prospectively examined functioning in BDD. In this study, which is to our knowledge the first prospective study of the course of BDD, psychosocial functioning was assessed at baseline and over 1-3 years (mean=2.7+/-0.9 years) of follow-up with the Global Assessment of Functioning scale (GAF), Social and Occupational Functioning Scale (SOFAS), and LIFE-RIFT (Range of Impaired Functioning Tool). Psychosocial functioning was poor during the follow-up period. Functioning remained stably poor over time on the SOFAS and LIFE-RIFT, although there was a trend for a gradual and slight improvement on the GAF over time. The cumulative probability of attaining functional remission on the GAF (score>70 for at least 2 consecutive months) during the follow-up period was only 5.7%. On the SOFAS, the cumulative probability of attaining functional remission (score>70 for at least 2 consecutive months) was 10.6%. BDD severity significantly predicted functioning on the GAF (p=0.0012), SOFAS (p=0.0017), and LIFE-RIFT (p=0.0015). A trend for a time-by-BDD severity interaction was found on the GAF (p=0.033) but not the SOFAS or LIFE-RIFT. More delusional BDD symptoms also predicted poorer functioning on all measures, although this finding was no longer significant when controlling for BDD severity. Functioning was not predicted, however, by age, gender, BDD duration, or a personality disorder. In conclusion, psychosocial functioning was poor over time, and few subjects attained functional remission. Greater BDD severity predicted poorer functioning.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.